BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20806364)

  • 1. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.
    Macher E; Dubos F; Garnier N; Delebarre M; De Berranger E; Thebaud E; Mazingue F; Leblond P; Martinot A
    Pediatr Blood Cancer; 2010 Oct; 55(4):662-7. PubMed ID: 20806364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI; Ribeiro Kde C; de Camargo B
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.
    Dubos F; Delebarre M; Martinot A
    Curr Opin Hematol; 2012 Jan; 19(1):39-43. PubMed ID: 22123661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
    J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
    Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
    Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
    Tamai Y; Imataki O; Kawakami K
    Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Clin Infect Dis; 2002 Sep; 35(6):678-83. PubMed ID: 12203164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
    Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
    Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
    Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
    Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.